vTv Therapeutics (VTVT) Current Leases (2019 - 2025)
vTv Therapeutics' (VTVT) quarterly Current Leases came in at $32000.0 in Q3 2025, down 82.32% year-on-year from $181000.0 in Q3 2024, and down 59.49% quarter-over-quarter from $79000.0 in Q2 2025.
vTv Therapeutics (VTVT) Current Leases (2019 - 2025) Analysis & Trends
vTv Therapeutics has disclosed Current Leases across 7 years of filings, most recently posting $32000.0 for Q3 2025.
- Current Leases for Q3 2025 came in at $32000.0, down 82.32% year-over-year; the trailing twelve-month figure through Sep 2025 was $32000.0 (down 82.32% YoY), and the FY2024 annual result was $169000.0, changed 0.0% from the prior year.
- Current Leases came in at $32000.0 for Q3 2025 at vTv Therapeutics, down from $79000.0 in the prior quarter.
- In the past five years, Current Leases ranged from a high of $208000.0 in Q3 2022 to a low of $32000.0 in Q3 2025.
- The 5-year median for Current Leases is $169000.0 (2021), against an average of $159526.3.
- Across the five-year window, Current Leases rose 19.12% in 2021 and tumbled 82.32% in 2025, its largest moves.
- vTv Therapeutics' Current Leases stood at $184000.0 in 2021, then retreated by 16.3% to $154000.0 in 2022, then gained by 9.74% to $169000.0 in 2023, then changed by 0.0% to $169000.0 in 2024, then plunged by 81.07% to $32000.0 in 2025.
- The last three Current Leases figures came in at $32000.0 (Q3 2025), $79000.0 (Q2 2025), and $125000.0 (Q1 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 42,980.09 |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 83,991.00 |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 7.40 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | vTv Therapeutics | 426.76 Mn | 426.76 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 32,000.00 |
| Jun 30, 2025 | 79,000.00 |
| Mar 31, 2025 | 125,000.00 |
| Dec 31, 2024 | 169,000.00 |
| Sep 30, 2024 | 181,000.00 |
| Jun 30, 2024 | 177,000.00 |
| Mar 31, 2024 | 173,000.00 |
| Dec 31, 2023 | 169,000.00 |
| Sep 30, 2023 | 165,000.00 |
| Jun 30, 2023 | 161,000.00 |
| Mar 31, 2023 | 157,000.00 |
| Dec 31, 2022 | 154,000.00 |
| Sep 30, 2022 | 208,000.00 |
| Jun 30, 2022 | 199,000.00 |
| Mar 31, 2022 | 191,000.00 |
| Dec 31, 2021 | 184,000.00 |
| Sep 30, 2021 | 176,000.00 |
| Jun 30, 2021 | 169,000.00 |
| Mar 31, 2021 | 162,000.00 |
| Dec 31, 2020 | 155,000.00 |